Elite Pharmaceuticals (ELTP)
(Delayed Data from OTC)
$0.62 USD
+0.01 (0.93%)
Updated Nov 3, 2025 03:59 PM ET
NA Value NA Growth NA Momentum NA VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its growth rate over the past 12 months. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ELTP 0.62 +0.01(0.93%)
Will ELTP be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for ELTP based on the 1-3 month trading system that more than doubles the S&P 500.

        
Zacks News for ELTP
Elite Pharma Stock Falls 32% Despite 52% Revenue Growth in FY2025
ELTP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ELTP
Elite Pharmaceuticals EVP Sells Massive Stock Shares!
Q1 2026 Elite Pharmaceuticals Inc Earnings Call Transcript
Elite Pharmaceuticals Inc (ELTP) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...
Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M
Elite Pharmaceuticals Inc Reports Q1 FY2026 Earnings: Revenue Surges to $40. ...